|
Dye [47]
|
Assam Province, India (1875–1950)
|
Anthroponotic VL (L. donovani)
|
Epidemic data from Rogers (1908) [69], McCombie Young (1924) [70], and Sen Gupta (1951) [71]
|
Discrete-time compartmental model
|
\(\times\)
|
|
Hasibeder [48]
|
\(\times\)
|
Canine leishmaniasis, L. infantum
|
\(\times\)
|
ODEs
|
\(\times\)
|
|
Dye [49]
|
Gozo island in Malta (June–July 1989)
|
Canine leishmaniasis, L. infantum
|
cross-sectional survey including age-structured serological data
|
Used results from ODEs in [48]
|
\(\times\)
|
|
Dye [50]
|
Tropical America, Mediterranean, and China
|
Canine and human zoonotic VL, L. infantum
|
Cohort study of dogs (Unpublished data, Quinell RJ, Courtenay O, and Dye C) and estimates from [49]
|
ODEs
|
\(\times\)
|
|
Stauch [51]
|
India, Nepal, Bangladesh (2006–2008)
|
Anthroponotic VL - L. donovani
|
KalaNet project (ClinicalTrials,gov NCT00318721)
|
ODEs
|
\(\times\)
|
|
Stauch [52]
|
Bihar, India (1980–1997)
|
anthroponotic VL
|
Treatment failure rate of antimonial treatment obtained from review of clinical trials [72]
|
ODEs
|
\(\times\)
|
|
Stauch [53]
|
India, Nepal, Bangladesh (2006–2008)
|
Anthroponotic VL
|
KalaNet project
|
ODEs
|
\(\times\)
|
|
Mubayi [3]
|
Bihar, India (2003–2005)
|
Anthroponotic VL
|
Monthly incidence from 21 districts
|
Staged-progression model
|
\(\times\)
|
|
ELmojtaba [54,55,56]
|
Sudan
|
Zoonotic VL
|
Parameter estimates from literature
|
ODE
|
\(\times\)
|
|
Sevá [57]
|
Brazil (approx. 1990s and 2000s)
|
Canine and human zoonotic VL, L. infantum
|
Parameters taken from published studies, oral communication, or assumed
|
ODEs
|
\(\times\)
|
|
Aparicio [58]
|
United States
|
TB
|
U.S. and Massachusetts Census data and Parameter estimates from literature
|
ODEs and an age-structured PDE model
|
Atmosphere
|
|
Lipsitch [59]
| |
TB
| |
Stochastic-deterministic hybrid model
|
Adherence
|
|
Mason [61]
|
United States (approx. 1995–2004)
|
Type II diabetes
|
Electronic Medical Records, Administrative medical and pharmacy claims data, and Healthcare Effectiveness Data
|
Discounted Markov Decision Process
|
Adherence
|
|
Hallet [62]
|
Zimbabwe (1980s–2000s)
|
HIV
|
HIV prevalence and sexual behaviour surveillance data
|
ODEs and a Bayesian Melding framework
|
Awareness
|
|
Mushayabasa [63]
|
\(\times\)
|
Hepatitis C
|
Epidemiological data from literature
|
ODEs
|
Awareness
|
|
Fenichel [64]
| | | |
Economic behavioral model/SIR
|
Awareness
|
